Cost of depression among adults in Japan in 2005
- PMID: 21851453
- DOI: 10.1111/j.1440-1819.2011.02237.x
Cost of depression among adults in Japan in 2005
Abstract
Aim: Major depression is expected to become the leading contributor to disease burden worldwide by 2020. Previous studies have shown that the societal cost of depression is not less than that of other major illnesses, such as cardiovascular diseases or AIDS. Nevertheless, the cost of depression in Japan has never been examined. The goal of the present study was to estimate the total cost of depression in Japan and to clarify the characteristics of this burden.
Methods: A prevalence-based approach was adopted to measure the total cost of depression. The total cost of depression was regarded as being comprised of the direct cost, morbidity cost and mortality cost. Diagnoses included in this study were depressive episodes and recurrent depressive disorder according to the ICD-10 or major depressive disorder according to the DSM-IV. Data were collected from publicly available statistics and the World Mental Health Japan Survey database.
Results: The total cost of depression among adults in Japan in 2005 was estimated to be ¥2.0 trillion. The direct cost was ¥0.18 trillion. The morbidity cost was ¥0.92 trillion, while the mortality cost was ¥0.88 trillion.
Conclusion: The societal costs caused by depression in Japan are enormous, as in other developed countries. Low morbidity costs and extremely high mortality costs are characteristic in Japan. Effective interventions for preventing suicide could reduce the societal costs of depression.
© 2011 The Authors. Psychiatry and Clinical Neurosciences © 2011 Japanese Society of Psychiatry and Neurology.
Similar articles
-
Cost of depression in Europe.J Ment Health Policy Econ. 2006 Jun;9(2):87-98. J Ment Health Policy Econ. 2006. PMID: 17007486
-
Costs of depression in Catalonia (Spain).J Affect Disord. 2011 Jul;132(1-2):130-8. doi: 10.1016/j.jad.2011.02.019. Epub 2011 Mar 12. J Affect Disord. 2011. PMID: 21402411
-
Costs associated with attempted suicide among individuals with bipolar disorder.J Ment Health Policy Econ. 2010 Jun;13(2):87-92. J Ment Health Policy Econ. 2010. PMID: 20919595
-
Cost-effectiveness of combination therapy versus antidepressant therapy for management of depression in Japan.Aust N Z J Psychiatry. 2009 Jun;43(6):539-47. doi: 10.1080/00048670902873664. Aust N Z J Psychiatry. 2009. PMID: 19440886 Review.
-
Estimating the cost of epilepsy in Europe: a review with economic modeling.Epilepsia. 2007 Dec;48(12):2224-33. doi: 10.1111/j.1528-1167.2007.01251.x. Epilepsia. 2007. PMID: 18088267 Review.
Cited by
-
Costs of psychotropics for outpatients with bipolar disorder in Japan; the MUSUBI 2016 survey.Ann Med. 2023 Dec;55(1):2224047. doi: 10.1080/07853890.2023.2224047. Ann Med. 2023. PMID: 37322994 Free PMC article.
-
Shared decision-making interventions for people with mental health conditions.Cochrane Database Syst Rev. 2022 Nov 11;11(11):CD007297. doi: 10.1002/14651858.CD007297.pub3. Cochrane Database Syst Rev. 2022. PMID: 36367232 Free PMC article. Review.
-
Medical Costs Associated with Insomnia Treatment with Suvorexant Monotherapy in Japan: Results from a Retrospective Cohort Study Using a Large-Scale Claims Database.Drugs Real World Outcomes. 2022 Jun;9(2):219-229. doi: 10.1007/s40801-021-00279-y. Epub 2022 Feb 7. Drugs Real World Outcomes. 2022. PMID: 35129832 Free PMC article.
-
Early Improvement with Vortioxetine Predicts Response and Remission: A Post Hoc Analysis of Data from a Clinical Trial Conducted in Japan.Neuropsychiatr Dis Treat. 2021 Dec 18;17:3735-3741. doi: 10.2147/NDT.S340309. eCollection 2021. Neuropsychiatr Dis Treat. 2021. PMID: 34955641 Free PMC article.
-
Cost-effectiveness analyses of augmented cognitive behavioral therapy for pharmacotherapy-resistant depression at secondary mental health care settings.Psychiatry Clin Neurosci. 2021 Nov;75(11):341-350. doi: 10.1111/pcn.13298. Epub 2021 Sep 17. Psychiatry Clin Neurosci. 2021. PMID: 34459077 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical